ADmit Therapeutics

ADmit Therapeutics

Biotechnology Research Sant Feliu De Llobregat, Barcelona, Es 13 employees ALM
Employees
13
Contacts
1
Emails
1

ADmit Therapeutics Overview

Headquarters
Sant Feliu De Llobregat, Barcelona, Es
Industry
Biotechnology Research
Employees
13
Founded
2017
Stock Symbol
ALM
Funding
6.1M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ADmit Therapeutics

ADmit Therapeutics is biotech company focused on the commerzalitation of the MAP-AD Test, the first epigenetic IVD Test for the prognosis of Alzheimer’s disease

ADmit Therapeutics Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

ADmit Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Ferran Prat Healthcare. Private Equity. Ceo. Board Chairman and Investor
View
Miguel A. Viribay Business Development, Cco. Life Science, Biotechnology & Diagnostic, Business, Acumen, Leadership, Strategy & Execution 🎯
View
Santiago Lozano Venture Funds Director. Partner
View
Sergio Vernis
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
VP / Head 1 profile
Director 1 profile
Manager 1 profile

Compare Similar Companies to ADmit Therapeutics